Prostate cancer aggressiveness locus on chromosome 7q32-q33 identified by linkage and allelic imbalance studies.

[1]  A. Goldstein,et al.  Familial chordoma, a tumor of notochordal remnants, is linked to chromosome 7q33. , 2001, American journal of human genetics.

[2]  J. Carpten,et al.  Linkage and association studies of prostate cancer susceptibility: evidence for linkage at 8p22-23. , 2001, American journal of human genetics.

[3]  J. Trent,et al.  Evidence for a prostate cancer linkage to chromosome 20 in 159 hereditary prostate cancer families , 2001, Human Genetics.

[4]  J. Carpten,et al.  Evaluation of linkage and association of HPC2/ELAC2 in patients with familial or sporadic prostate cancer. , 2001, American journal of human genetics.

[5]  E. Green,et al.  Mutational and functional analyses reveal that ST7 is a highly conserved tumor-suppressor gene on human chromosome 7q31 , 2001, Nature Genetics.

[6]  D. Schaid,et al.  Analysis of the prostate cancer-susceptibility locus HPC20 in 172 families affected by prostate cancer. , 2001, American journal of human genetics.

[7]  Siavash Ghaffari,et al.  A candidate prostate cancer susceptibility gene at chromosome 17p , 2001, Nature Genetics.

[8]  G. Cancel-Tassin,et al.  PCAP is the major known prostate cancer predisposing locus in families from south and west Europe , 2001, European Journal of Human Genetics.

[9]  J. Stanford,et al.  Genetics of prostate cancer: too many loci, too few genes. , 2000, American journal of human genetics.

[10]  J. Carpten,et al.  A genetic epidemiological study of hereditary prostate cancer (HPC) in Finland: frequent HPCX linkage in families with late-onset disease. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[11]  T. Rebbeck,et al.  Association of HPC2/ELAC2 genotypes and prostate cancer. , 2000, American journal of human genetics.

[12]  E. Gillanders,et al.  Analysis of HPC1, HPCX, and PCaP in Icelandic hereditary prostate cancer , 2000, Human Genetics.

[13]  J. Witte,et al.  Replication linkage study for prostate cancer susceptibility genes , 2000, The Prostate.

[14]  D V Conti,et al.  Genomewide scan for prostate cancer-aggressiveness loci. , 2000, American journal of human genetics.

[15]  J. Witte,et al.  Identification and fine mapping of a region showing a high frequency of allelic imbalance on chromosome 16q23.2 that corresponds to a prostate cancer susceptibility locus. , 2000, Cancer research.

[16]  F. Macciardi,et al.  A tumor suppressor locus in familial and sporadic chordoma maps to 1p36 , 2000, International journal of cancer.

[17]  R C Elston,et al.  Haseman and Elston revisited , 2000, Genetic epidemiology.

[18]  D J Schaid,et al.  Evidence for a prostate cancer-susceptibility locus on chromosome 20. , 2000, American journal of human genetics.

[19]  N. Niikawa,et al.  Construction of a physical and transcript map flanking the imprinted MEST/PEG1 region at 7q32. , 2000, Genomics.

[20]  E. Green,et al.  Definitive functional evidence for a tumor suppressor gene on human chromosome 7q31.1 neighboring the Fra7G site , 2000, Oncogene.

[21]  J. Sgouros,et al.  A 700-kb physical map of a region of 16q23.2 homozygously deleted in multiple cancers and spanning the common fragile site FRA16D. , 2000, Cancer research.

[22]  R. Richards,et al.  Chromosomal fragile site FRA16D and DNA instability in cancer. , 2000, Cancer research.

[23]  E. Goode,et al.  Linkage analysis of 150 high‐risk prostate cancer families at 1q24‐25 , 2000, Genetic epidemiology.

[24]  J. Witte,et al.  A genome screen of multiplex sibships with prostate cancer. , 2000, American journal of human genetics.

[25]  J. Xu.  Combined analysis of hereditary prostate cancer linkage to 1q24-25: results from 772 hereditary prostate cancer families from the International Consortium for Prostate Cancer Genetics. , 2000, American journal of human genetics.

[26]  J. Adams,et al.  cDNA cloning of human muskelin and localisation of the muskelin (MKLN1) gene to human chromosome 7q32 and mouse chromosome 6 B1/B2 by physical mapping and FISH , 1999, Cytogenetic and Genome Research.

[27]  M. Skolnick,et al.  Prostate cancer susceptibility locus HPC1 in Utah high-risk pedigrees. , 1999, Human molecular genetics.

[28]  M. Poo,et al.  Plexins Are a Large Family of Receptors for Transmembrane, Secreted, and GPI-Anchored Semaphorins in Vertebrates , 1999, Cell.

[29]  B. Snel,et al.  Domains in plexins: links to integrins and transcription factors. , 1999, Trends in biochemical sciences.

[30]  J. Carpten,et al.  In Swedish families with hereditary prostate cancer, linkage to the HPC1 locus on chromosome 1q24-25 is restricted to families with early-onset prostate cancer. , 1999, American journal of human genetics.

[31]  A. Whittemore,et al.  No evidence of linkage for chromosome 1q42.2-43 in prostate cancer. , 1999, American journal of human genetics.

[32]  Kenneth F. Manly,et al.  Overview of QTL mapping software and introduction to Map Manager QT , 1999, Mammalian Genome.

[33]  E. Goode,et al.  Evidence for a rare prostate cancer-susceptibility locus at chromosome 1p36. , 1999, American journal of human genetics.

[34]  Josephine C. Adams,et al.  Muskelin, a novel intracellular mediator of cell adhesive and cytoskeletal responses to thrombospondin‐1 , 1998, The EMBO journal.

[35]  David I. Smith,et al.  Differential loss of heterozygosity at 7q31.2 in follicular and papillary thyroid tumors , 1998, Oncogene.

[36]  I. Campbell,et al.  Loss of heterozygosity on chromosomes 7p, 7q, 9p and 11q is an early event in ovarian tumorigenesis , 1998, Oncogene.

[37]  S. Scherer,et al.  Molecular characterization of a common fragile site (FRA7H) on human chromosome 7 by the cloning of a simian virus 40 integration site. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[38]  W. Vogel,et al.  Predisposing gene for early-onset prostate cancer, localized on chromosome 1q42.2-43. , 1998, American journal of human genetics.

[39]  J. Klingelhöfer,et al.  Transcription of a novel mouse semaphorin gene, M-semaH, correlates with the metastatic ability of mouse tumor cell lines. , 1998, Cancer research.

[40]  E. Bergstralh,et al.  Prognostic significance of allelic imbalance of chromosome arms 7q, 8p, 16q, and 18q in stage T3N0M0 prostate cancer , 1998, Genes, chromosomes & cancer.

[41]  S. Nishizuka,et al.  Commonly deleted region on the long arm of chromosome 7 in differentiated adenocarcinoma of the stomach. , 1997, British Journal of Cancer.

[42]  G. Casey,et al.  Four regions of allelic imbalance on 17q12‐qter associated with high‐grade breast tumors , 1997, Genes, chromosomes & cancer.

[43]  F. Collins,et al.  Early age at diagnosis in families providing evidence of linkage to the hereditary prostate cancer locus (HPC1) on chromosome 1. , 1997, Cancer research.

[44]  E. Goode,et al.  Linkage analysis of 49 high-risk families does not support a common familial prostate cancer-susceptibility gene at 1q24-25. , 1997, American journal of human genetics.

[45]  J. Oesterling,et al.  Prostate cancer susceptibility locus on chromosome 1q: a confirmatory study. , 1997, Journal of the National Cancer Institute.

[46]  P. Comoglio,et al.  Control of invasive growth by hepatocyte growth factor (HGF) and related scatter factors. , 1997, Cytokine & growth factor reviews.

[47]  D A Meyers,et al.  Major Susceptibility Locus for Prostate Cancer on Chromosome 1 Suggested by a Genome-Wide Search , 1996, Science.

[48]  A. Scarpa,et al.  Chromosome 7q allelic losses in pancreatic carcinoma. , 1996, Cancer research.

[49]  D. Roberts,et al.  Regulation of tumor growth and metastasis by thrombospondin‐1 , 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[50]  G. Gyapay,et al.  A radiation hybrid map of the human genome. , 1996, Human molecular genetics.

[51]  C. Croce,et al.  The FHIT Gene, Spanning the Chromosome 3p14.2 Fragile Site and Renal Carcinoma–Associated t(3;8) Breakpoint, Is Abnormal in Digestive Tract Cancers , 1996, Cell.

[52]  O. Cussenot,et al.  Loss of heterozygosity at 7q31 is a frequent and early event in prostate cancer. , 1995, Clinical cancer research : an official journal of the American Association for Cancer Research.

[53]  D. Bostwick,et al.  Frequent loss of heterozygosity at 7q31.1 in primary prostate cancer is associated with tumor aggressiveness and progression. , 1995, Cancer research.

[54]  M. Becich,et al.  Chordomas: pathological features; ploidy and silver nucleolar organizing region analysis , 1995, Acta Neuropathologica.

[55]  P. Troncoso,et al.  Loss of heterozygosity in human primary prostate carcinomas: a possible tumor suppressor gene at 7q31.1. , 1994, Cancer research.

[56]  I. Bièche,et al.  (C-A)n microsatellite repeat D7S522 is the most commonly deleted region in human primary breast cancer. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[57]  K. Dameron,et al.  Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1. , 1994, Science.

[58]  D. Gleason,et al.  Histologic grading of prostate cancer: a perspective. , 1992, Human pathology.

[59]  E. Small,et al.  Independent association of angiogenesis index with outcome in prostate cancer. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[60]  F. Mostofi,et al.  Inflammatory infiltrate (prostatitis) in whole mounted radical prostatectomy specimens from black and white patients is not an etiology for racial difference in prostate specific antigen. , 2000, The Journal of urology.

[61]  U. G. Dailey.  Cancer,Facts and Figures about. , 2022, Journal of the National Medical Association.